Absolute Markets Insights (AMI) reports a robust forecast for the immunotherapy drugs market during the 2021-2030 period. In its newly released report, AMI anticipates the market will grow at 10.9% as increasing prevalence of target diseases and favorable drug discovery regulation. AMI reports that the market stood at a valuation of US$ 133.43 Bn in 2020.
Absolute Markets Insights has recently added an extensive report to its repository titled Immunotherapy Drugs Market. The latest market study provides a lucid understanding of the Immunotherapy Drugs sector and the report scrutinizes the data by using primary and secondary research techniques. Moreover, it also sheds light on various dynamic aspects of businesses such as client requirements, demanding products or services, shares, and raw material. Additionally, the data has been examined by means of effective analysis technique such as, SWOT and Porter’s Five analysis. This in return also gives a descriptive overview of strengths, weaknesses, threats, and opportunities.
Key Players Operating in Global Immunotherapy Drugs Market: AbbVie Inc., Amgen Inc., AstraZeneca, Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Merck & Co., Inc., and Novartis AG, Pfizer Inc., amongst other market participants.
Please click the link below to get a full report:https://www.absolutemarketsinsights.com/reports/Global-Immunotherapy-Drugs-Market-2021—2029-919
Based on type, the global immunotherapy drugs market has been primarily segmented into monoclonal antibodies, immune checkpoint inhibitors, interferons & interleukins, vaccines, and others. Monoclonal antibodies segment held the largest market share in 2020 and is anticipated to retain the share over the forecast period. Some monoclonal antibodies (MABs) are used in immunotherapy. They function by activating the immune system and assisting it in its fight against cancer. Other MABs work by interfering with immune system cells. Checkpoint inhibitors, for example, are a kind of immunotherapy. Checkpoint inhibitors prevent the immune system from attacking cancer cells by inhibiting proteins.
Based on disease indication, the global immunotherapy drugs market has been classified into cancer, autoimmune diseases, infectious diseases, and others. Cancer segment is further segmented into breast cancer, bladder cancer, brain cancer (brain tumor), colorectal (colon) cancer, melanoma, kidney cancer, and others. Cancer held a substantial market share in 2020 owing to increasing cancer incidences globally. In 2020, According to data from GLOBOCAN, there will be nearly 2,261,419 (11.7%) new breast cancer cases, 2,206,771 (11.4%) new lung cancer cases, and 1,931,590 (10%) new colorectum cancer cases. Breast cancer is one of every four cancers diagnosed in women worldwide.
Based on route of administration, the global immunotherapy drugs market has been classified into topical, oral, intravenous (IV), and others. Oral route of administration accounted for the highest share in 2020. The benefits associated with oral medication administration and key companies focused on developing oral drugs for immunotherapy have attributed towards the segment’s highest share in the global market.
Based on end users, the global immunotherapy drugs market has been classified into hospitals, clinics, and others. The hospital segment held the highest market share in 2020 and is predicted to be the fastest growing segment over the projection period due to rising hospital spending on immunotherapies and the need for advanced treatments that are presently only available in hospitals.
Global Immunotherapy Drugs Market: Key Segmentation
By Type
- Monoclonal Antibodies
- Immune Checkpoint Inhibitors
- Interferons & Interleukins
- Vaccines
- Others
By Disease Indication
- Cancer
- Breast Cancer
- Bladder Cancer
- Brain Cancer (Brain Tumor)
- Colorectal (Colon) Cancer
- Melanoma
- Kidney Cancer
- Others
- Autoimmune Diseases
- Infectious Diseases
- Others
By Route of Administration
- Oral
- Intravenous (IV)
- Topical
- Others
By End Users
- Hospitals
- Clinics
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
Contact Us:
Company: Absolute Markets Insights
Email Id: sales@absolutemarketsinsights.com
Phone: IN +917400242424, US +1-510-420-1213
Contact Name: Shreyas Tanna
Website: www.absolutemarketsinsights.com/
